Brain Imaging and Neuroimaging Market by Imaging Techniques (Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography, Electroencephalography, Magnetoencephalography, Functional Near-Infrared Spectroscopy), by Application (Diagnostics, Research, Therapeutic Monitoring), by End-User (Hospitals, Diagnostic Imaging Centers, Research Institutes, Ambulatory Care Centers), and by Technology (Structural Imaging, Functional Imaging, Molecular Imaging); Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Brain Imaging And Neuroimaging Market was valued at USD 7.9 billion in 2023 and will surpass USD 15.4 billion by 2030; growing at a CAGR of 10.1% during 2024 - 2030. The brain imaging and neuroimaging market is primarily driven by advanced imaging techniques that enable detailed visualization and diagnosis of neurological conditions. Among these techniques, Magnetic Resonance Imaging (MRI) holds the largest share, being widely regarded for its ability to produce high-resolution images of the brain's structure without the use of radiation. MRI has revolutionized the diagnosis of neurological conditions, including brain tumors, stroke, and neurodegenerative diseases, making it the most preferred technique in clinical settings. The non-invasive nature of MRI, combined with its superior soft-tissue imaging capabilities, has ensured its dominance in the market. MRI’s ability to generate detailed structural images of the brain without exposing patients to harmful radiation has made it indispensable in both routine diagnostics and advanced research. As the demand for early and accurate detection of brain disorders rises, MRI’s role becomes even more crucial in clinical practices. Its integration with technologies like functional MRI (fMRI) further enhances its versatility, enabling the visualization of both anatomical structures and brain activity, thereby contributing to its dominant position in the imaging techniques segment. Application Segment is Fastest Growing Owing to Rising Diagnostic Needs The application segment in the brain imaging and neuroimaging market is broad, encompassing diagnostics, research, and therapeutic monitoring. Of these, the diagnostic application segment is the fastest growing, driven by the increasing prevalence of neurological disorders, such as Alzheimer's, Parkinson's disease, and multiple sclerosis, as well as growing awareness of brain health. Diagnostic imaging techniques are essential in detecting these conditions early, allowing for timely intervention and management. This has resulted in a rising demand for advanced neuroimaging tools to assist healthcare professionals in accurate diagnoses. The diagnostic segment is growing rapidly due to an increasing reliance on non-invasive imaging techniques like MRI, CT, and PET, which offer critical insights into the brain's condition. As more patients seek medical consultations for neurological symptoms and the healthcare sector emphasizes preventive care, diagnostic neuroimaging applications are set to witness significant expansion. The advancements in imaging technologies that enhance sensitivity, specificity, and image quality are further propelling growth within this segment, especially in the areas of early disease detection and personalized treatment strategies. End-User Segment is Largest Owing to Hospital Dominance Within the end-user segment, hospitals are the largest consumers of brain imaging and neuroimaging technologies. Hospitals utilize a wide range of imaging techniques, such as MRI and CT, for the diagnosis and management of brain-related disorders. These medical facilities invest heavily in state-of-the-art imaging equipment to provide accurate, fast, and non-invasive diagnostic services. Hospitals remain the largest user group due to their capacity to offer comprehensive neuroimaging services, catering to patients with various neurological conditions, from routine assessments to complex diagnostics. Hospitals' dominance in the end-user segment is primarily attributed to their role in providing emergency care and specialized neurological services, where advanced imaging technologies are essential. These institutions are at the forefront of adopting cutting-edge neuroimaging techniques to improve patient outcomes, including pre-surgical planning, monitoring of disease progression, and assessing treatment effectiveness. Additionally, hospitals benefit from the growing adoption of hybrid imaging technologies that combine MRI and PET scans for more precise brain diagnostics, reinforcing their leadership in the market. Technology Segment is Fastest Growing Owing to Functional Imaging Advancements The technology segment in brain imaging and neuroimaging encompasses structural imaging, functional imaging, and molecular imaging. Functional imaging is the fastest-growing sub-segment, largely due to its ability to provide real-time insights into brain activity, offering critical information for both diagnostics and research. Techniques such as functional MRI (fMRI) and positron emission tomography (PET) are transforming our understanding of brain function, enabling researchers and clinicians to observe neural activity associated with various mental and neurological conditions. As functional imaging technologies advance, they provide invaluable data for studying cognition, emotion, and behavioral patterns. Functional imaging's rapid growth is further fueled by its applications in studying brain connectivity and mental health disorders, such as depression, schizophrenia, and autism. The ability to detect and monitor brain activity non-invasively has made functional imaging a key tool in both clinical and research settings. Furthermore, with the rise of precision medicine, functional imaging is playing an increasingly pivotal role in understanding the individual variability of brain functions, which is fueling the demand for these technologies in the market. North America is Largest Region Owing to High Adoption Rates and Healthcare Infrastructure North America is the largest region in the brain imaging and neuroimaging market, driven by the high adoption of advanced imaging technologies and robust healthcare infrastructure. The United States, in particular, leads the market due to its well-established healthcare system, which consistently integrates cutting-edge medical technologies, including MRI, CT, PET, and functional imaging. Furthermore, the growing prevalence of neurological conditions and increased funding for research are contributing to the expansion of the market in this region. Hospitals, diagnostic centers, and research institutes in North America are investing heavily in advanced neuroimaging equipment, making it a significant market for manufacturers. The high healthcare expenditure in North America allows for the widespread availability and utilization of the latest neuroimaging technologies. The presence of major industry players, such as GE Healthcare, Siemens Healthineers, and Philips Healthcare, further bolsters the market growth. Additionally, increasing government initiatives to support brain health research and the early diagnosis of neurological diseases are propelling the demand for brain imaging technologies, particularly in the United States and Canada. Leading Companies and Competitive Landscape The brain imaging and neuroimaging market is highly competitive, with numerous global players leading in technology development and market share. Major companies such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems are at the forefront, offering a wide range of imaging systems that cater to both diagnostic and research needs. These companies are investing heavily in R&D to develop innovative technologies, such as AI-powered imaging solutions and hybrid imaging systems, to improve the accuracy and efficiency of neuroimaging procedures. The competitive landscape is characterized by technological advancements, strategic collaborations, mergers, and acquisitions. Companies are increasingly focusing on partnerships with hospitals and research institutions to enhance the reach of their products. Additionally, the growing focus on precision medicine and personalized treatment is driving companies to innovate and offer tailored solutions. As the demand for advanced neuroimaging technologies continues to rise, leading companies are likely to benefit from ongoing advancements in imaging modalities, particularly in functional and molecular imaging. Recent Developments: • Siemens Healthineers launched an AI-enhanced MRI system, improving diagnostic precision for brain imaging. • GE Healthcare unveiled a next-generation PET scanner optimized for neurodegenerative disease imaging. • Philips acquired Capsule Technologies to streamline diagnostic imaging data integration for improved neuroimaging outcomes. • Canon Medical announced collaborations to advance brain mapping through innovative fNIRS technology. • Medtronic invested in AI startups focused on enhancing imaging software for better neurological diagnostics. List of Leading Companies: • Siemens Healthineers • GE Healthcare • Philips Healthcare • Canon Medical Systems Corporation • Hitachi Medical Corporation • Medtronic • Shimadzu Corporation • Samsung Medison • Elekta AB • Esaote SpA • Bruker Corporation • Mindray Medical International Limited • Neusoft Medical Systems • Fujifilm Holdings Corporation • Advanced Brain Monitoring Report Scope: Report Features Description Market Size (2023) USD 7.9 Billion Forecasted Value (2030) USD 15.4 Billion CAGR (2024 – 2030) 10.1% Base Year for Estimation 2023 Historic Year 2022 Forecast Period 2024 – 2030 Report Coverage Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments Segments Covered Brain Imaging and Neuroimaging Market by Imaging Techniques (Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography, Electroencephalography, Magnetoencephalography, Functional Near-Infrared Spectroscopy), by Application (Diagnostics, Research, Therapeutic Monitoring), by End-User (Hospitals, Diagnostic Imaging Centers, Research Institutes, Ambulatory Care Centers), and by Technology (Structural Imaging, Functional Imaging, Molecular Imaging) Regional Analysis North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) Major Companies Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems Corporation, Hitachi Medical Corporation, Medtronic, Shimadzu Corporation, Samsung Medison, Elekta AB, Esaote SpA, Bruker Corporation, Mindray Medical International Limited, Neusoft Medical Systems, Fujifilm Holdings Corporation, Advanced Brain Monitoring Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements